Study Update EURECA

The EURECA study is progressing adequately. It is a very ambitious and challenging project involving 50 sites from 11 countries, aiming at including 2000 patients!

The training sessions were completed with all sites by webcast; an additional session will be organized by end of September; a recorded session is also available for all participants in case they need a refresh some aspects. Of course the whole team in Seville and Antwerp are available for questions by email and phone.

Obtaining the IRBs approvals and signing of the agreements with each site has proven to be challenging task. Because of the complexity of addressing the different regulations in each country and site, we have suffered some delays, but currently 17 sites from 6 countries (6 from Spain, 4 from Turkey and Serbia, and one from Albania, Kosovo and Montenegro) are ready to recruit patients. We hope to announce the activation of more site soon.

Recruitment is progressing at a reasonable pace. As of today, 100 patients have been recruited at 11 sites, including all type of group patients (CRE, CRAB, CSE, and admitted controls) with type of targeted infections (bloodstream infections, complicated urinary tract infections, pneumonia and intra-abdominal infections). The electronic Case Reporting Form platform is working properly. Finally, we have started with the monitoring activities to guarantee the quality of the data for the firsts patients included as planned.

We highly appreciate the commitment, effort and collaboration of all the investigators involved, the national coordinators, and the members of the partners teams. Once again, thank you very much for your commitment and continued support.

 

EURECA Project Lead